After treatment for cancer, the use of routine scanning should only be used where this is beneficial to the patient.
The recommendation does not have more information, evidence or additional references.
Bisphosphonate therapy should be reviewed with each patient after 3 to 5 years, and discontinuation of treatment should be considered. This should follow a shared decision-making conversation that includes the risks and benefits of continued treatment. If bisphosphonate treatment is discontinued and no new fracture occurs, use of FRAX can be considered after 18 months for risedronate and ibandronate, 2 years for alendronate, and 3 years for zoledronate to inform whether treatment should be ...
A systematic review "Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis" concluded that among patients who underwent lumbar puncture, atraumatic needles were associated with a decreased incidence of subsequent headache. to dural puncture and the need for patients to return to the hospital for additional therapy, and had similar efficacy to conventional needles. These findings offer clinicians and stakeholders a comprehensive assessment and high-quality ...
Everyone should consider vitamin D supplementation all year round.
People who have restricted access to sunlight (e.g. those living in institutions or who cover their skin), or have dark skin, should consider supplementation all year round. Vitamin D testing should be reserved for people at high risk from deficiency and avoided as part of routine investigation of widespread pain alone. Repeat testing is not normally indicated in those taking supplements.